SURVANTA

This brand name is authorized in Brazil, Canada, Ecuador, Hong Kong, Nigeria, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug SURVANTA contains one active pharmaceutical ingredient (API):

1 Beractant UNII S866O45PIG - BERACTANT

Read about Beractant

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R07AA02	Natural phospholipids	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AA Lung surfactants
Discover more medicines within R07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 543714090000017, 543714090000117
Country: CA	Health Products and Food Branch	Identifier(s): 02016109
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 12-MBE-0614
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 80091
Country: HK	Department of Health Drug Office	Identifier(s): 35445
Country: NG	Registered Drug Product Database	Identifier(s): B4-9922
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100078677
Country: SG	Health Sciences Authority	Identifier(s): 06720P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 17603011H, 17603012H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680656080193
Country: US	FDA, National Drug Code	Identifier(s): 0074-1040